Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_1

57%

Ph not_applicable

14%

Ph early_phase_1

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

Phase 1Safety & dosage

4(66.7%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Detailed Status

Completed6

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)

Phase 14 (66.7%)

N/A1 (16.7%)

Trials by Status

completed686%

terminated114%

Recent Activity

0 active trials

Showing 5 of 7

completed

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

NCT02055586

completedphase_1

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

NCT02146222

completednot_applicable

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

NCT00276770

completedphase_1

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00575393

completedearly_phase_1

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

NCT01825902

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT02055586

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Completed

NCT02146222Phase 1

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Completed

NCT00276770Not Applicable

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

Completed

NCT00575393Phase 1

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Completed

NCT01825902Early Phase 1

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Completed

NCT01243359Phase 1

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Completed

NCT00070239Phase 1

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Terminated

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7